Related Experiment Video
Updated: Mar 17, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial
Antonina Mikocka-Walus1,2,3, Peter Bampton4,5, David Hetzel6
1School of Nursing and Midwifery and Sansom Institute for Health Research, University of South Australia, Adelaide, 5001, Australia. Antonina.mikocka-walus@york.ac.uk.
Cognitive-behavioural therapy (CBT) did not improve physical or mental health outcomes in inflammatory bowel disease (IBD) patients over 24 months. Further research should explore personalized psychotherapy approaches for IBD management.
Area of Science:
- Gastroenterology
- Psychiatry
- Clinical Trials
Background:
- The effectiveness of psychotherapy, specifically cognitive-behavioural therapy (CBT), in managing inflammatory bowel disease (IBD) remains controversial.
- While CBT may alleviate psychological distress like anxiety and depression in IBD patients, its impact on physical disease course and long-term outcomes is under-researched.
Purpose of the Study:
- To investigate the long-term impact of CBT on the disease course of patients with inflammatory bowel disease (IBD).
- To compare standard care plus CBT with standard care alone in a pragmatic randomized controlled trial over a 24-month period.
Main Methods:
- A two-arm pragmatic randomized controlled trial comparing standard care plus CBT (+CBT) with standard care (SC) alone.
- CBT was delivered over 10 weeks, either face-to-face (F2F) or online (cCBT).
- Data were analyzed using linear mixed-effects models to assess disease activity, blood parameters, mental health, coping, and quality of life over 24 months.
Main Results:
- CBT did not significantly alter disease activity indices (CDAI, SCCAI) or key blood parameters (CRP, Hb, platelet, WCC) at 24 months.
- No significant improvements were observed in mental health, coping strategies, or quality of life among patients receiving CBT compared to standard care alone.
- All tested outcomes showed no statistically significant difference between the +CBT and SC groups (p > 0.05).
Conclusions:
- Cognitive-behavioural therapy (CBT) does not appear to influence the disease course of inflammatory bowel disease (IBD) over a 24-month period.
- High attrition rates, particularly in the CBT group, suggest a need for more personalized psychotherapy approaches in future IBD trials.
- Consideration should be given to hybrid models, combining online and one-to-one therapist delivery, to improve engagement and adherence in IBD psychotherapy interventions.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...